News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sirtris Pharmaceuticals (SIRT) CEO Christoph Westphal Selected by Biotech CEOs As Outstanding Individual


10/16/2008 3:00:41 PM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, has been awarded Outstanding Individual by his CEO peers in the biotech community at The Laguna Biotech Meeting.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES